Suchergebnisse - (Person:"Jimenez-Fonseca, Paula")

PubPharm (212)

21

Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Lee, E. | Jiménez-Fonseca, P. | Galán-Moral, R. | +8

22

CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

enthalten in: Clinical epigenetics | 2023

von Tejedor, J. | Peñarroya, A. | Gancedo-Verdejo, J. | +22

23

CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

enthalten in: Clinical epigenetics | 2023

von Tejedor, J. | Peñarroya, A. | Gancedo-Verdejo, J. | +22

24

Clinicians' and Advanced Cancer Patients' Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Lee, E. | Jiménez-Fonseca, P. | Carmona-Bayonas, A. | +7

25

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2023

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

26

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations : data from the SEPTRALU study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Mitjavila, M. | Jimenez-Fonseca, P. | Belló, P. | +21

27

Decoding risk : Caravaggio's insights into risk factors for anticoagulation in cancer-associated thrombosis

enthalten in: European journal of internal medicine | 2023

von López Robles, J. | Carmona-Bayonas, A. | Jiménez-Fonseca, P.

CommentOn: Eur J Intern Med. 2023 Jun;112:29-36. - PMID 36774305

28

The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Lee, E. | Jiménez-Fonseca, P. | Hernández, R. | +7

29

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Kelley, R. | Ueno, M. | Yoo, C. | +119

CommentIn: Lancet. 2023 Jun 3;401(10391):1826-1827. - PMID 37075782

30

Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer

enthalten in: Revista de oncología | 2023

von Rodríguez-Gonzalez, A. | Carmona-Bayonas, A. | Hernandez San Gil, R. | +9